ClinConnect ClinConnect Logo
Search / Trial NCT04961437

Impact of Dyspnea, Regional Lung Ventilation, and Diaphragmatic Function During de Novo Acute Respiratory Failure

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jul 5, 2021

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Acute Respiratory Failure Diaphragm Dyspnea Eit

ClinConnect Summary

This clinical trial is studying how to better manage acute respiratory failure, which is a serious condition where the lungs cannot get enough oxygen to the body. The trial aims to understand how patients feel short of breath (dyspnea), how well their lungs are working in different areas, and how their diaphragm (a muscle that helps us breathe) is functioning. By observing these factors, researchers hope to identify who is at risk of needing a breathing tube (intubation) and to improve treatments that help patients breathe without invasive methods.

To participate in this study, individuals must be over 18 years old and show signs of acute respiratory insufficiency, such as low oxygen levels and a fast breathing rate, while needing significant oxygen support. Patients who have certain chronic lung diseases, severe respiratory issues, or other specific health concerns may not be eligible. Those who join the trial can expect to undergo various assessments to monitor their breathing and lung function, helping doctors understand the best ways to support patients experiencing acute respiratory failure.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \> 18
  • * Acute respiratory insufficiency defined by the three following items :
  • 1. PaO2/ FiO2 \<300
  • 2. Respiratory rate \> 25/min
  • 3. Oxygen support \> 10L/min or High Flow nasal oxygen (HFNO)
  • Non opposition by the patient to be included
  • Social insurance
  • Exclusion Criteria:
  • Respiratory acidosis (pH \< 7,35 PaCO2 \> 45mmHg or 6kPa)
  • Chronic respiratory disease ( COPD, bronchiectasis...)
  • Cardiogenic Acute lung oedema
  • Non intubation decision at randomisation
  • Contraindication for Electro-impedance tomography-belt placement (chest trauma with rib fractures, thoracic wound, chest tube).
  • Uncommunicative patient (Glasgow coma scale \<12)
  • Guardianship or curators for vulnerable patients.

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Paris, , France

Patients applied

0 patients applied

Trial Officials

Martin DRES, MD PhD

Study Director

Assistance Publique - Hôpitaux de Paris

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials